Your session is about to expire
← Back to Search
Device
transcranial direct current stimulator (tDCS) for Cocaine Dependence
Phase 2
Waitlist Available
Led By Abhishek Datta, PhD
Research Sponsored by Soterix Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-tdcs), post-tdcs sessions (approx. week 6), follow-up (1 month, 3 month)
Awards & highlights
Study Summary
This study is evaluating whether a home-based tDCS device is safe and feasible for patients with chronic migraine.
Eligible Conditions
- Cocaine Use Disorder
- Cocaine Dependence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-tdcs), post-tdcs sessions (approx. week 6), follow-up (1 month, 3 month)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-tdcs), post-tdcs sessions (approx. week 6), follow-up (1 month, 3 month)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Cocaine Craving from Baseline (Obsessive-Compulsive Cocaine Scale score)
Secondary outcome measures
Change in Anxiety symptoms from Baseline (HAM-A score)
Change in Depression symptoms from Baseline (Ham-D score)
Change in Quality of Life from Baseline (WHOQOL-BREF score)
+2 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Active tDCS with Cognitive Reappraisal (CR)Experimental Treatment2 Interventions
Active Transcranial Direct Current Stimulation (tDCS) (Soterix Medical mini-CT tDCS stimulator), and Cognitive Reappraisal (CR)
Group II: Active tDCSExperimental Treatment1 Intervention
Active Transcranial Direct Current Stimulation (tDCS), (Soterix Medical mini-CT tDCS stimulator)
Group III: Sham tDCSPlacebo Group1 Intervention
Sham (Placebo) Transcranial Direct Current Stimulation (tDCS), Soterix Medical mini-CT tDCS stimulator
Find a Location
Who is running the clinical trial?
Soterix MedicalLead Sponsor
10 Previous Clinical Trials
332 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiOTHER
860 Previous Clinical Trials
524,416 Total Patients Enrolled
Abhishek Datta, PhDPrincipal InvestigatorSoterix Medical
2 Previous Clinical Trials
75 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Icahn School of Medicine at Mount Sinai
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger